LCM
CHRS icon

Landscape Capital Management’s Coherus Oncology CHRS Stock Holding History

Landscape Capital Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-16,058
Closed -$127K – 676
2022
Q4 		$127K Buy
+16,058
New +$124K 0.02% 673
2018
Q1 		– Sell
-13,148
Closed -$116K – 497
2017
Q4 		$116K Buy
+13,148
New +$141K 0.01% 602

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Landscape Capital Management's CHRS Position: Q1 2023 in Review

Landscape Capital Management sold out of Coherus Oncology (CHRS) in Q1 2023, closing a stake of 16,058 shares — an estimated $127K sold.

Landscape Capital Management first reported a position in CHRS in Q4 2017 and held it in 2 quarters. The position peaked at $127K in Q4 2022. 163 funds tracked by Wall St. Rank hold CHRS as of Q1 2023.

  • Landscape Capital Management reported no remaining Coherus Oncology position as of Q1 2023 after selling out during the quarter.
  • Landscape Capital Management sold 16,058 Coherus Oncology shares in Q1 2023, an estimated $127K.
  • Landscape Capital Management first reported a position in Coherus Oncology in Q4 2017 and held it in 2 quarters.
  • Landscape Capital Management's Coherus Oncology position peaked at $127K in Q4 2022.
  • 163 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2023.

Based on Landscape Capital Management's 13F filing for Q1 2023, filed 10 May 2023.